Medical University of Vienna, University Hospital Cologne, University College Dublin, Vilnius University Hospital Santaros Klinikos, University Medical Center Utrecht, Karolinska Institute, European Clinical Research Infrastructure Network (ECRIN), European University Cyprus, Hacettepe University, University Hospital Center of Porto, Capital Region of Denmark, University of Bergen, Slovak Academy of Sciences, University of Galway, University of Verona, Institut National de la santé et de la recherche médicale (INSERM), University of Belgrade, University of Bern, Israel Ministry of Health, Medical University of Bialystok, Instituto de Salud Carlos III, Sorbonne Paris Cité,
Centre for the Evaluation of Vaccination (CEV)The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is continued need for phase 2 & 3 vaccine trials to reach long-term, large-scale immunity of the entire European population. VACCELERATE will be the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials. The overall objective of VACCELERATE is to connect all European stakeholders ...